Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Arnold Palmer Hospital for Children
mi
from
Orlando, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Arnold Palmer Hospital for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Larry C. Deeb, M.D., P.A.
mi
from
Tallahassee, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Larry C. Deeb, M.D., P.A.
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Nancy Wright, MD, PA Pedicatric Endocrinology
mi
from
Tallahassee, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Nancy Wright, MD, PA Pedicatric Endocrinology
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Pediatric Endocrinology
mi
from
Tallahassee, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Pediatric Endocrinology
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
University of South Florida
mi
from
Tampa, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Riley Hospital for Children
mi
from
Indianapolis, IN
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Barry J. Reiner MD
mi
from
Baltimore, MD
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Barry J. Reiner MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Massachusetts General Hospital
mi
from
Boston, MA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Boston Children's Hospital
mi
from
Boston, MA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Baystate Medical Center
mi
from
Springfield, MA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Children's Mercy Hospital
mi
from
Kansas City, MO
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Morristown Medical Center
mi
from
Morristown, NJ
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Morristown Medical Center
mi
from
Morristown, NJ
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Women and Children's Hospital of Buffalo
mi
from
Buffalo, NY
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Women and Children's Hospital of Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Winthrop University Hospital
mi
from
Mineola, NY
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Diabetes & Endocrine Center for Children and Young Adults
mi
from
Sleepy Hollow, NY
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Diabetes & Endocrine Center for Children and Young Adults
mi
from
Sleepy Hollow, NY
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Cleveland Clinic
mi
from
Cleveland, OH
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
University of Washington, Seattle Children's Hospital
mi
from
Seattle, WA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
University of Washington, Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Universitair Ziekenhuis Brussel
mi
from
Brussels,
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Universitair Ziekenhuis Brussel
mi
from
Brussels,
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
University of Alabama School of Medicine
mi
from
Birmingham, AL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
University of Alabama School of Medicine
mi
from
Birmingham, AL
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Pediatric Endocrinology Associates
mi
from
Long Beach, CA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Pediatric Endocrinology Associates
mi
from
Long Beach, CA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Center of Excellence in Diabetes & Endrocinology
mi
from
Sacramento, CA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Center of Excellence in Diabetes & Endrocinology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Pediatric Endrocrinology of San Diego Medical Group
mi
from
San Diego, CA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Pediatric Endrocrinology of San Diego Medical Group
mi
from
San Diego, CA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Pediatric Endocrine Associates
mi
from
Greenwood Village, CO
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Pediatric Endocrine Associates
mi
from
Greenwood Village, CO
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Memorial Healthcare System
mi
from
Hollywood, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Memorial Healthcare System
mi
from
Hollywood, FL
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Nicklaus Children's Hospital
mi
from
Miami, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Nicklaus Children's Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Nemour's Children's Clinic
mi
from
Pensacola, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Nemour's Children's Clinic
mi
from
Pensacola, FL
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Pediatric Endocrine Associates
mi
from
Tampa, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Pediatric Endocrine Associates
mi
from
Tampa, FL
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Van Meter Pediatric Endocrinology, P.C.
mi
from
Atlanta, GA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Van Meter Pediatric Endocrinology, P.C.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Palm Research Center
mi
from
Las Vegas, NV
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Palm Research Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Medical University of South Carolina
mi
from
Charleston, SC
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
BMG/The Endocrine Clinic
mi
from
Memphis, TN
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
BMG/The Endocrine Clinic
mi
from
Memphis, TN
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
University of Virginia Health System
mi
from
Charlottesville, VA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Yale University
mi
from
New Haven, CT
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Children's Hospitals and Clinics - Minnesota
mi
from
Saint Paul, MN
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Children's Hospitals and Clinics - Minnesota
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise
Status: Enrolling
Updated:  10/12/2017
University of Michigan
mi
from
Ann Arbor, MI
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise
Status: Enrolling
Updated: 10/12/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
Obesity, Insulin Resistance, and Bone Metabolism in Adolescents With PCOS: Effects of Insulin Sensitizers Versus Oral Contraceptives
Status: Enrolling
Updated:  10/16/2017
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
Obesity, Insulin Resistance, and Bone Metabolism in Adolescents With PCOS: Effects of Insulin Sensitizers Versus Oral Contraceptives
Status: Enrolling
Updated: 10/16/2017
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hypoglycemia and the Mineralocorticoid Receptor
Hypoglycemia and the Mineralocorticoid Receptor
Status: Enrolling
Updated:  10/16/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Hypoglycemia and the Mineralocorticoid Receptor
Hypoglycemia and the Mineralocorticoid Receptor
Status: Enrolling
Updated: 10/16/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Protandim and the Metabolic Syndrome
Protandim and the Metabolic Syndrome: A Preliminary Study to Define Protein Signatures That Change Along With Lowered Oxidative Stress Measured as F2 Isoprostanes or TBARS and Inflammation Measured as hsCRP
Status: Enrolling
Updated:  10/16/2017
University of Colorado Denver
mi
from
Aurora, CO
Protandim and the Metabolic Syndrome
Protandim and the Metabolic Syndrome: A Preliminary Study to Define Protein Signatures That Change Along With Lowered Oxidative Stress Measured as F2 Isoprostanes or TBARS and Inflammation Measured as hsCRP
Status: Enrolling
Updated: 10/16/2017
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome (3ELM Study)
A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome
Status: Enrolling
Updated:  10/17/2017
Rush University Medical Center
mi
from
Chicago, IL
A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome (3ELM Study)
A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome
Status: Enrolling
Updated: 10/17/2017
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Acute Effect of Exenatide on Brain Glucose Metabolism
Effect of Exenatide on Brain Glucose Uptake in Relations to Pancreatic, Adipose Tissue, and Hepatic Function
Status: Enrolling
Updated:  10/19/2017
Texas Diabetes Institute and UTHSCSA
mi
from
San Antonio, TX
Acute Effect of Exenatide on Brain Glucose Metabolism
Effect of Exenatide on Brain Glucose Uptake in Relations to Pancreatic, Adipose Tissue, and Hepatic Function
Status: Enrolling
Updated: 10/19/2017
Texas Diabetes Institute and UTHSCSA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver.
Lipid and Carbohydrate Metabolism: Effects of Exercise
Status: Enrolling
Updated:  10/19/2017
YCCI/YNNH Hospital Research Unit
mi
from
New Haven, CT
Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver.
Lipid and Carbohydrate Metabolism: Effects of Exercise
Status: Enrolling
Updated: 10/19/2017
YCCI/YNNH Hospital Research Unit
mi
from
New Haven, CT
Click here to add this to my saved trials
Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
Reducing Medical Risks in Individuals With Bipolar Disorder: Enhancing Outcomes With Aripiprazole
Status: Enrolling
Updated:  10/19/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
Reducing Medical Risks in Individuals With Bipolar Disorder: Enhancing Outcomes With Aripiprazole
Status: Enrolling
Updated: 10/19/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials